MedPath

The Positive Outlook Study: a randomised controlled trial evaluating the effectiveness of an online self management program for men living with HIV

Not Applicable
Completed
Conditions
Human Immunodeficiency Virus (HIV)
Infection - Acquired immune deficiency syndrome (AIDS / HIV)
Mental Health - Depression
Registration Number
ACTRN12612000642886
Lead Sponsor
Monash University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
120
Inclusion Criteria

HIV positive (self report)
Over 18 years old
Male
Self identifies as gay or MSM (men who have sex with men)
Ability to independently access a computer and use the internet for at least 90minutes per week for 7 weeks
Ability to read, write and understand English

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary Outcome 1: outcomes of health education as assessed by the heiQ[Baseline, immediately after intervention completion and at 12 week follow up.];Primary Outcome 2: domain specific self efficacy as assessed by a survey specifically designed for this study[Baseline, immediately after intervention completion and at 12 week follow up.];Primary Outcome 3: quality of life as assessed by the PROQOL-HIV[Baseline, immediately after intervention completion and at 12 week follow up.]
Secondary Outcome Measures
NameTimeMethod
Social support as measured by the Duke Social Support Index (DSSI)[Baseline, immediately after intervention completion and at 12 week follow up.];Self efficacy as measured by the Generalised Self Efficacy Scale (GSE)[Baseline, immediately after intervention completion and at 12 week follow up.];General health and quality of life as measured by the SF12[Baseline, immediately after intervention completion and at 12 week follow up.];Depression as measured by the Depression Anxiety and Stress Scale (DASS21)[Baseline, immediately after intervention completion and at 12 week follow up.];Adjustment to HIV as measured by the Mental Adjustment to HIV Scale (MAH)[Baseline, immediately after intervention completion and at 12 week follow up.]
© Copyright 2025. All Rights Reserved by MedPath